English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background:   To present the operative and post-operative comparison between patients who underwent tumor-bed closure with sutures compared with bovine serum albumin–glutaraldehyde (BioGlue ® ) tissue sealant only.Methods:   We retrospectively analyzed data from our ongoing database of 507 eligible patients who underwent open NSS nephron-sparing surgery in our department between January 1995 and May 2014. Patients had tumor-bed closure with sealant adhesive (255 patients) or standard suture technique (252 patients). Demographic, clinical and perioperative data were compared between the two groups, by Chi-square test or by Fisher–Irwin exact test for categorical variables, and by t test for differences in means or by Wilcoxon rank sum test for continuous variables. A multivariate analysis was also done.Results:   Patients’ baseline characteristics showed similar distribution of the analyzed parameters among both groups, with few differences: younger age in the sealant group (65.4 versus 68.4 years, p = 0.01) and slightly larger mass size in the suture group (4.0 versus 3.9 cm, p = 0.03). Ischemia time was significantly shorter in the sealant group (21.8 versus 27.0 minutes, p = 0001). Blood loss and transfusion rate (0.8% versus 11.9%, p = 0.0001) were significantly less in the sealant group. A multivariate analysis showed date of surgery and blood loss as the major parameters affecting transfusion rate.Conclusions:   Closing the tumor bed with BioGlue ®  tissue adhesive is feasible, safe, can shorten ischemia time and potentially reduce transfusion rate.

therapeutic advances in urology

Bovine serum albumin–glutaraldehyde (BioGlue<sup>®</sup>) tissue adhesive<i>versus</i>standard renorrhaphy following renal mass enucleation: a retrospective comparison

Bovine serum albumin–glutaraldehyde (BioGlue®) tissue adhesiveversusstandard renorrhaphy following renal mass enucleation: a retrospective comparison

Bovine serum albumin–glutaraldehyde (BioGlue^®) tissue adhesiveversusstandard renorrhaphy following renal mass enucleation: a retrospective comparison